Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Study Demonstrates Impact of Prescription Refill Programs on Medication Adherence

[PR Newswire] – WOONSOCKET, R.I., Nov. 16, 2015 /PRNewswire/ — New research by the CVS Health Research Institute is the first to show the impact of prescription refill programs on medication adherence. The . . . → Read More: Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Study Demonstrates Impact of Prescription Refill Programs on Medication Adherence Similar Articles: Stock Update (NYSE:CVS): CVS Health Research Institute Study Finds that Initial Prescription Fills Can Accurately Predict Long-term Medication Adherence Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Publishes First Findings that Show Narrow Pharmacy Networks Can Help Improve Medication Adherence Market Update (NYSE:CVS): CVS Health Launches ScriptSync(TM) to Make Medication Adherence Easier for Patients who Have Multiple Prescriptions